Editas Medicine

Editas Medicine EDIT Stock

$2.17   1.401868%
Add to favorites
Market Cap
$334.92M
LOW - HIGH [24H]
$2.01 - $2.21
VOLUME [24H]
$2.79M
P/E Ratio
0
Earnings per share
-$0.54
ISIN
US28106W1036
Price   Prediction

Editas Medicine Price Chart

Sorry, that's all we've gotfor now...

Editas Medicine (EDIT) stock price today is 2.17 USD on Tech Market Large (+1.4% on the day). Updated .

Editas Medicine EDIT Financial and Trading Overview

Editas Medicine stock price 2.17 USD
Previous Close 2.14 USD
Open 2.14 USD
Bid 1.56 USD x 200
Ask 2.17 USD x 1000
Day's Range 2.01 - 2.21 USD
52 Week Range 1.66 - 3.94 USD
Volume 2.79M USD
Avg. Volume 2.78M USD
Market Cap 334.92M USD
Beta (5Y Monthly) 2.077
PE Ratio (TTM) N/A
EPS (TTM) -0.54 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 6.1 USD

EDIT Valuation Measures

Enterprise Value 158.66M USD
Trailing P/E N/A
Forward P/E -3.0187104
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 6.7216015
Price/Book (mrq) 3.9454546
Enterprise Value/Revenue 3.184
Enterprise Value/EBITDA -1.956

Trading Information

Editas Medicine Stock Price History

Beta (5Y Monthly) 2.077
52-Week Change -15.89%
S&P500 52-Week Change 13.32%
52 Week High 3.94 USD
52 Week Low 1.66 USD
50-Day Moving Average 2.63 USD
200-Day Moving Average 2.7 USD

EDIT Share Statistics

Avg. Volume (3 month) 2.78M USD
Avg. Daily Volume (10-Days) 2.31M USD
Shares Outstanding 154.34M
Float 116.19M
Short Ratio 16.04
% Held by Insiders 1.11%
% Held by Institutions 87.29%
Shares Short 38.72M
Short % of Float 25.24%
Short % of Shares Outstanding 25.19%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -144.95%
Operating Margin (ttm) -166.96%
Gross Margin -73.30%
EBITDA Margin -162.77%

Management Effectiveness

Return on Assets (ttm) -24.69%
Return on Equity (ttm) -147.43%

Income Statement

Revenue (ttm) 49.83M USD
Revenue Per Share (ttm) 0.43 USD
Quarterly Revenue Growth (yoy) 37.39%
Gross Profit (ttm) -36527000 USD
EBITDA -81105000 USD
Net Income Avi to Common (ttm) -72225000 USD
Diluted EPS (ttm) -0.54
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 190.2M USD
Total Cash Per Share (mrq) 1.23 USD
Total Debt (mrq) 13.94M USD
Total Debt/Equity (mrq) 16.49 USD
Current Ratio (mrq) 2.822
Book Value Per Share (mrq) 0.55

Cash Flow Statement

Operating Cash Flow (ttm) -110206000 USD
Levered Free Cash Flow (ttm) -34032624 USD

Profile of Editas Medicine

Country United States
State MA
City Cambridge
Address 11 Hurley Street
ZIP 02141
Phone 617 401 9000
Website https://www.editasmedicine.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 87

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

Q&A For Editas Medicine Stock

What is a current EDIT stock price?

Editas Medicine EDIT stock price today per share is 2.17 USD.

How to purchase Editas Medicine stock?

You can buy EDIT shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Editas Medicine?

The stock symbol or ticker of Editas Medicine is EDIT.

Which industry does the Editas Medicine company belong to?

The Editas Medicine industry is Biotechnology.

How many shares does Editas Medicine have in circulation?

The max supply of Editas Medicine shares is 154.34M.

What is Editas Medicine Price to Earnings Ratio (PE Ratio)?

Editas Medicine PE Ratio is now.

What was Editas Medicine earnings per share over the trailing 12 months (TTM)?

Editas Medicine EPS is -0.54 USD over the trailing 12 months.

Which sector does the Editas Medicine company belong to?

The Editas Medicine sector is Healthcare.

Editas Medicine EDIT included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 25136.27 USD —
-0.91
7.74B USD — 24872.41 USD — 25423.09 USD — — 7.74B USD —
us US Tech Global Select Market Com NQGS US 12378.66 USD —
-0.9
— — 12248.6 USD — 12520.36 USD — — — —
us US Tech Biotechnology NBI US 7211.27 USD —
-0.5
— — 7149.19 USD — 7238.9 USD — — — —
us US Tech Health Care IXHC US 1368.29 USD —
-0.34
— — 1358.68 USD — 1373.65 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
$2.2T
Total marketcap
$72.47B
Total volume
BTC 59.40%   •   ETH 10.13%
Dominance
Select currency